Analyst Ratings For NASDAQ:NVCR – NovoCure (NASDAQ:NVCR)
Today, Mizuho reiterated its Buy rating on NASDAQ:NVCR – NovoCure (NASDAQ:NVCR) with a price target of $32.00.
Some recent analyst ratings include
- 4/18/2018-Mizuho Reiterated Rating of Buy .
- 11/20/2017-JPMorgan Chase Reiterated Rating of Buy.
- 10/27/2017-Wedbush Reiterated Rating of Outperform.
- 5/24/2017-Wells Fargo Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 4/18/2017-Aegis Reiterated Rating of Buy.
- 4/4/2017-JMP Securities Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:NVCR – NovoCure (NASDAQ:NVCR)
NASDAQ:NVCR – NovoCure (NASDAQ:NVCR) has insider ownership of 16.70% and institutional ownership of 42.83%.
- On 4/3/2018 Yoram Palti, Insider, sold 60,000 with an average share price of $20.32 per share and the total transaction amounting to $1,219,200.00.
- On 3/29/2018 Yoram Palti, CTO, sold 30,000 with an average share price of $21.67 per share and the total transaction amounting to $650,100.00.
- On 2/23/2018 Michael J Ambrogi, COO, sold 8,458 with an average share price of $19.83 per share and the total transaction amounting to $167,722.14.
- On 2/23/2018 Todd Christopher Longsworth, General Counsel, sold 6,591 with an average share price of $19.83 per share and the total transaction amounting to $130,699.53.
- On 2/23/2018 Wilhelmus Cm Groenhuysen, CFO, sold 13,351 with an average share price of $19.83 per share and the total transaction amounting to $264,750.33.
- On 1/29/2018 Asaf Danziger, CEO, sold 13,974 with an average share price of $24.02 per share and the total transaction amounting to $335,655.48.
- On 1/29/2018 Todd Christopher Longsworth, General Counsel, sold 11,630 with an average share price of $24.00 per share and the total transaction amounting to $279,120.00.
Recent Trading Activity for NASDAQ:NVCR – NovoCure (NASDAQ:NVCR)
Shares of NASDAQ:NVCR – NovoCure closed the previous trading session at 24.45 up +1.20 5.16% with 22.850000381469727 shares trading hands.